Akari Therapeutics (AKTX) Amortization - Deferred Charges (2015 - 2020)
Akari Therapeutics recorded quarterly Amortization - Deferred Charges of $900.0 billion in Q3 2020, up 103836085.56% quarter-over-quarter from $866749.0 in Q2 2020, and up 223856885.09% year-over-year from N/an in Q4 2019.
Akari Therapeutics' Amortization - Deferred Charges history runs 4 years deep, the most recent figure standing at $900.0 billion for Q3 2020.
- In Q3 2020, Amortization - Deferred Charges rose 223856885.09% year-over-year to $900.0 billion; the TTM figure through Sep 2020 stood at $900.0 billion (up 223857247.48% YoY), while the FY2019 annual figure was $321956.0, down 44.96% from the prior year.
- Amortization - Deferred Charges came in at $900.0 billion for Q3 2020 at Akari Therapeutics, up from $866749.0 in the prior quarter.
- In the past five years, Amortization - Deferred Charges ranged from a high of $900.0 billion in Q3 2020 to a low of $5190.0 in Q1 2019.
- A 3-year average of $100.0 billion and a median of $585000.0 in 2018 frame the typical range for Amortization - Deferred Charges.
- Across the five-year window, Amortization - Deferred Charges tumbled 44.96% in 2019 and soared 223856885.09% in 2020, its largest moves.
- Akari Therapeutics' Amortization - Deferred Charges stood at $585000.0 in 2018, then sank by 44.96% to $321956.0 in 2019, then jumped by 279540924.24% to $900.0 billion in 2020.
- According to Business Quant data, Amortization - Deferred Charges over the past three periods registered $900.0 billion, $866749.0, and $288705.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 900.00 Bn |
| Sep 30, 2020 | 900.00 Bn |
| Jun 30, 2020 | 866,749.00 |
| Jun 30, 2020 | 866,749.00 |
| Mar 31, 2020 | 288,705.00 |
| Mar 31, 2020 | 288,705.00 |
| Dec 31, 2019 | 321,956.00 |
| Dec 31, 2019 | 321,956.00 |
| Sep 30, 2019 | 402,042.00 |
| Sep 30, 2019 | 402,042.00 |
| Jun 30, 2019 | 606,508.00 |
| Jun 30, 2019 | 606,508.00 |
| Mar 31, 2019 | 5,190.00 |
| Mar 31, 2019 | 5,190.00 |
| Dec 31, 2018 | 585,000.00 |
| Dec 31, 2018 | 585,000.00 |
| Sep 30, 2018 | 585,000.00 |
| Sep 30, 2018 | 585,000.00 |
| Sep 30, 2015 | -22.97 Mn |
| Sep 30, 2015 | -22.97 Mn |